Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

SCWorx (WORX) Shares Outstanding (Diluted Average) (2021 - 2025)

SCWorx's Shares Outstanding (Diluted Average) history spans 5 years, with the latest figure at $7.3 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 398.76% to $7.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.3 million, a 398.76% increase, with the full-year FY2025 number at $7.3 million, up 398.76% from a year prior.
  • Shares Outstanding (Diluted Average) hit $7.3 million in Q4 2025 for SCWorx, up from $4.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for WORX hit a ceiling of $11.6 million in Q3 2022 and a floor of $797871.0 in Q4 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $5.2 million across 5 years, with a median of $3.0 million in 2025.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): plummeted 92.41% in 2022 and later soared 398.76% in 2025.
  • Tracing WORX's Shares Outstanding (Diluted Average) over 5 years: stood at $10.5 million in 2021, then plummeted by 92.41% to $797871.0 in 2022, then rose by 29.43% to $1.0 million in 2023, then soared by 41.25% to $1.5 million in 2024, then soared by 398.76% to $7.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for WORX at $7.3 million in Q4 2025, $4.9 million in Q3 2025, and $4.2 million in Q2 2025.